Thrombosis: Latest Advances and Prospects

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Hematology".

Deadline for manuscript submissions: 25 February 2025 | Viewed by 20

Special Issue Editor


E-Mail Website
Guest Editor
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30307, USA
Interests: thrombosis

Special Issue Information

Dear Colleagues,

Thromboembolic disorders are among the leading causes of morbidity and mortality worldwide. Thrombosis is a result of a complex interaction between various inherited and acquired hypercoagulable states. The last almost two decades have seen significant advances and interest in this field. One such example is the addition of direct oral anticoagulants to the anticoagulant armamentarium, which has revolutionized the treatment of thrombotic disorders. The recent COVID-19 pandemic, with its associated coagulopathy, caused a resurgence of interest in the thrombo-inflammatory pathway, while highlighting the need for better diagnostic and treatment approaches. The ongoing trials targeting FXIa inhibition offer a different approach to the treatment of thromboembolic disorders. Nevertheless, significant gaps still remain in our understanding of clot structure and causation, and there continues to be a need for improved diagnostic modalities and more effective and safer treatments, particularly in patients at high risk for thrombosis and bleeding complications.  

In this Special Issue, we invite submissions focusing on novel information about the pathophysiology of arterial and venous clots, advances in biomarkers and diagnostic modalities, novel treatment targets, and practical aspects of the management of patients with thromboembolic disorders. We welcome original research manuscripts, review articles, and brief reports on issues related to advances in understanding, diagnosis, and treatment of thromboembolism.

We look forward to receiving your submissions.

Dr. Manila Gaddh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • thromboembolism
  • venous thrombosis
  • arterial thrombosis
  • anticoagulation

Published Papers

This special issue is now open for submission.
Back to TopTop